Colombia
· Delayed Price · Currency is COP Clínica de Marly Statistics
Total Valuation
Clínica de Marly has a market cap or net worth of COP 90.76 billion. The enterprise value is -57.60 billion.
| Market Cap | 90.76B |
| Enterprise Value | -57.60B |
Important Dates
The next estimated earnings date is Friday, November 15, 2024.
| Earnings Date | Nov 15, 2024 |
| Ex-Dividend Date | Nov 5, 2024 |
Share Statistics
Clínica de Marly has 10.68 million shares outstanding.
| Shares Outstanding | 10.68M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 43.43% |
| Owned by Institutions (%) | 2.47% |
| Float | 3.90M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | 4.78 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.84 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -3.03 |
Financial Position
The company has a current ratio of 2.83, with a Debt / Equity ratio of 0.02.
| Current Ratio | 2.83 |
| Quick Ratio | 2.72 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.13 |
| Debt / FCF | 0.63 |
| Interest Coverage | 41.56 |
Financial Efficiency
Return on equity (ROE) is 12.75% and return on invested capital (ROIC) is 9.77%.
| Return on Equity (ROE) | 12.75% |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | 9.77% |
| Revenue Per Employee | 446.56M |
| Profits Per Employee | 81.86M |
| Employee Count | 833 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 8,500.00 |
| 200-Day Moving Average | 8,500.00 |
| Relative Strength Index (RSI) | 100.00 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Clínica de Marly had revenue of COP 371.99 billion and earned 68.19 billion in profits.
| Revenue | 371.99B |
| Gross Profit | 134.96B |
| Operating Income | 86.51B |
| Pretax Income | 100.09B |
| Net Income | 68.19B |
| EBITDA | 91.66B |
| EBIT | 86.51B |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 166.05 billion in cash and 11.94 billion in debt, giving a net cash position of 154.10 billion or 14,431.80 per share.
| Cash & Cash Equivalents | 166.05B |
| Total Debt | 11.94B |
| Net Cash | 154.10B |
| Net Cash Per Share | 14,431.80 |
| Equity (Book Value) | 566.23B |
| Book Value Per Share | n/a |
| Working Capital | 187.83B |
Cash Flow
In the last 12 months, operating cash flow was 27.76 billion and capital expenditures -8.77 billion, giving a free cash flow of 19.00 billion.
| Operating Cash Flow | 27.76B |
| Capital Expenditures | -8.77B |
| Free Cash Flow | 19.00B |
| FCF Per Share | 1,778.95 |
Margins
Gross margin is 36.28%, with operating and profit margins of 23.26% and 18.33%.
| Gross Margin | 36.28% |
| Operating Margin | 23.26% |
| Pretax Margin | 26.91% |
| Profit Margin | 18.33% |
| EBITDA Margin | 24.64% |
| EBIT Margin | 23.26% |
| FCF Margin | 5.11% |
Dividends & Yields
This stock pays an annual dividend of 1,305.00, which amounts to a dividend yield of 15.35%.
| Dividend Per Share | 1,305.00 |
| Dividend Yield | 15.35% |
| Dividend Growth (YoY) | -65.41% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 13.73% |
| Buyback Yield | n/a |
| Shareholder Yield | 15.35% |
| Earnings Yield | n/a |
| FCF Yield | 20.93% |
Stock Splits
The last stock split was on March 17, 2003. It was a forward split with a ratio of 1.025.
| Last Split Date | Mar 17, 2003 |
| Split Type | Forward |
| Split Ratio | 1.025 |
Scores
Clínica de Marly has an Altman Z-Score of 2.38. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.38 |
| Piotroski F-Score | n/a |